Literature DB >> 23127371

Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance.

Feiran Lou1, James Huang, Camelia S Sima, Joseph Dycoco, Valerie Rusch, Peter B Bach.   

Abstract

OBJECTIVE: At present, there is no consensus on the optimal strategy for follow-up care after curative resection for lung cancer. We sought to understand the patterns of recurrence and second primary lung cancer, and their mode of detection, after resection for early-stage non-small cell lung cancer in patients who were followed by routine surveillance computed tomography scan.
METHODS: We reviewed the outcomes of consecutive patients who underwent resection for early-stage non-small cell lung cancer at Memorial Sloan-Kettering Cancer Center between 2004 and 2009.
RESULTS: A total of 1294 consecutive patients with early-stage non-small cell lung cancer underwent resection. The median length of follow-up was 35 months. Recurrence was diagnosed in 257 patients (20%), and second primary lung cancer was diagnosed in 91 patients (7%). The majority of new primary cancers (85 [93%]) were identified by scheduled routine computed tomography scan, as were a smaller majority of recurrences (157 [61%]). During the first 4 years after surgery, the risk of recurrence ranged from 6% to 10% per person-year but decreased thereafter to 2%. Conversely, the risk of second primary lung cancer ranged from 3% to 6% per person-year and did not diminish over time. Additional testing after false-positive surveillance computed tomography scan results was performed for 329 patients (25%), but only 4 of these patients (0.3%) experienced complications as a result of subsequent invasive diagnostic procedures.
CONCLUSIONS: Almost all second primary cancers and the majority of recurrences were detected by post-therapeutic surveillance computed tomography scan. The risk of recurrence for early-stage non-small cell lung cancer survivors persisted during the first 4 years after resection, and vigilance in surveillance should be maintained.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23127371     DOI: 10.1016/j.jtcvs.2012.09.030

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  83 in total

1.  Pros: long-term CT scan follow-up should be the standard of care in patients who are curatively treated for an early-stage non-small cell lung cancer.

Authors:  Waël C Hanna
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard.

Authors:  Deniz Yalman; Ugur Selek
Journal:  Ann Transl Med       Date:  2015-07

3.  Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.

Authors:  Chad G Rusthoven; Brian D Kavanagh; Sana D Karam
Journal:  Ann Transl Med       Date:  2015-07

Review 4.  New techniques for assessing response after hypofractionated radiotherapy for lung cancer.

Authors:  Sarah A Mattonen; Kitty Huang; Aaron D Ward; Suresh Senan; David A Palma
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

Review 5.  Is there a room for immune checkpoint inhibitors in early stage non-small cell lung cancer?

Authors:  Elisa Gobbini; Matteo Giaj Levra
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

6.  Extremely Didactic Experience About the Postoperative Recurrence of Lung Cancer: a Case Report.

Authors:  Taiji Kuwata; Akihiro Taira; Yusuke Nabe; Shuichi Shinohara; Fumihiro Tanaka
Journal:  Indian J Surg Oncol       Date:  2018-04-30

7.  Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.

Authors:  Lucas W Thornblade; Michael S Mulligan; Katherine Odem-Davis; Billanna Hwang; Rachel L Waworuntu; Erika M Wolff; Larry Kessler; Douglas E Wood; Farhood Farjah
Journal:  Ann Thorac Surg       Date:  2018-07-19       Impact factor: 4.330

8.  Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.

Authors:  Alexander J Antoniou; Charles Marcus; Abdel K Tahari; Richard L Wahl; Rathan M Subramaniam
Journal:  J Nucl Med       Date:  2014-04-28       Impact factor: 10.057

9.  Design, Synthesis, and Evaluation of a Neurokinin-1 Receptor-Targeted Near-IR Dye for Fluorescence-Guided Surgery of Neuroendocrine Cancers.

Authors:  Ananda Kumar Kanduluru; Madduri Srinivasarao; Philip S Low
Journal:  Bioconjug Chem       Date:  2016-09-02       Impact factor: 4.774

10.  Early postoperative complications after middle lobe-preserving surgery for secondary lung cancer.

Authors:  Yuho Maki; Shinichi Toyooka; Junichi Soh; Hiromasa Yamamoto; Seiichiro Sugimoto; Masaomi Yamane; Takahiro Oto; Shinichiro Miyoshi
Journal:  Surg Today       Date:  2016-09-14       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.